Back to all Entrepreneurs

Nikos Moschos

PD Neurotechnology
PD Neurotechnology
2021
Year Selected

Athens, Grece
Location(s)

Follow Nikos Moschos on LinkedIn

Nikos is an experienced Chief Business Development Officer with a background in the hospital and healthcare industry. He is also a strong sales professional with expertise in business planning, sales, contract management, business development, and marketing strategy. Nikos is the founder and Business Director of PD Neurotechnology Ltd, where he has been working full-time since September 2016. Additionally, Nikos holds an MBA from MIT Sloan, which further enhances his business knowledge and expertise.

PD Neurotechnology is a medical technology company that has developed a monitoring device designed to track every movement of patients suffering from Parkinson's disease. The company's wearable non-invasive device facilitates continuous monitoring, tracing, recording, and processing of a variety of symptoms frequently presented in the disease. The device works in conjunction with a mobile app that facilitates patient-doctor interaction, enabling patients and healthcare providers to improve clinical decision-making and promote patient-physician interaction. PD Neurotechnology is disrupting the medical device sector by providing an innovative solution for continuous monitoring of Parkinson's disease symptoms, which was previously not possible with traditional monitoring methods. The selling points of PD Neurotechnology's device include its non-invasive nature, ease of use, and ability to provide continuous monitoring and tracking of symptoms, leading to improved clinical decision-making and patient care. Additionally, the mobile app facilitates patient-doctor interaction, promoting better communication and collaboration between healthcare providers and their patients.

Programs


ScaleUp Program
PD Neurotechnology Founder & Business Director at PD Neurotechnology Ltd.

Year Founded

2015

Year Selected

2021

Stage

Early Growth (Series A, Series B)

Team Size

21-50

Total Capital Raised

€5M

Healthcare & Life Sciences

Wearables, Devices and Hardware

Relevant Resources

See All

Endeavor Scale-up Program: 2nd Cohort

Jan 10, 2021
Blog